Pharmaceutical CDMOs are quickly exposed to cybersecurity risk and complex compliance requirements, which they manage in the global network due to sensitive data. Problems such as third-party weaknesses and limited adoption of zero-trust framework combine to create a challenge. This article highlig...
Drug supply chains are facing increasing risks from geopolitical and environmental disorders. CDMO plays an important role in ensuring medical supply stability by using flexible strategies. As the industry develops, small-molecule CDMOs should embrace innovation and agility to balance supply and de...